Display options
Cite
Hokland P, Hokland M, Cotter F. The Nobel Prize for Medicine awarded for cancer therapy by inhibition of negative immune regulation. Br J Haematol. 2018;183(5):698-700doi: 10.1111/bjh.15694.
Hokland, P., Hokland, M., & Cotter, F. (2018). The Nobel Prize for Medicine awarded for cancer therapy by inhibition of negative immune regulation. British journal of haematology, 183(5), 698-700. https://doi.org/10.1111/bjh.15694
Hokland, Peter, et al. "The Nobel Prize for Medicine awarded for cancer therapy by inhibition of negative immune regulation." British journal of haematology vol. 183,5 (2018): 698-700. doi: https://doi.org/10.1111/bjh.15694
Hokland P, Hokland M, Cotter F. The Nobel Prize for Medicine awarded for cancer therapy by inhibition of negative immune regulation. Br J Haematol. 2018 Dec;183(5):698-700. doi: 10.1111/bjh.15694. PMID: 30488426.
Copy Download .nbib Format: NLM
Share it on

Br J Haematol. 2018 Dec;183(5):698-700. doi: 10.1111/bjh.15694.

The Nobel Prize for Medicine awarded for cancer therapy by inhibition of negative immune regulation.

British journal of haematology

Peter Hokland, Marianne Hokland, Finbarr Cotter

Affiliations

  1. Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  2. Department of Biomedicine, Aarhus University, Aarhus, Denmark.
  3. Centre for Haematology-Oncology, Barts Cancer Institute, Barts and London School of Medicine and Dentistry, London, UK.

PMID: 30488426 DOI: 10.1111/bjh.15694

[No abstract available.]

Keywords: Nobel prize 2018; cancer; checkpoint immunotherapy; personalized medicine

Publication Types